1. Home
  2. CDT vs HCTI Comparison

CDT vs HCTI Comparison

Compare CDT & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • HCTI
  • Stock Information
  • Founded
  • CDT 2019
  • HCTI 2020
  • Country
  • CDT United States
  • HCTI United States
  • Employees
  • CDT N/A
  • HCTI N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • HCTI Retail: Computer Software & Peripheral Equipment
  • Sector
  • CDT Health Care
  • HCTI Technology
  • Exchange
  • CDT Nasdaq
  • HCTI Nasdaq
  • Market Cap
  • CDT 2.2M
  • HCTI 2.4M
  • IPO Year
  • CDT N/A
  • HCTI 2021
  • Fundamental
  • Price
  • CDT $2.51
  • HCTI $0.02
  • Analyst Decision
  • CDT
  • HCTI
  • Analyst Count
  • CDT 0
  • HCTI 0
  • Target Price
  • CDT N/A
  • HCTI N/A
  • AVG Volume (30 Days)
  • CDT 725.7K
  • HCTI 722.7M
  • Earning Date
  • CDT 08-11-2025
  • HCTI 08-18-2025
  • Dividend Yield
  • CDT N/A
  • HCTI N/A
  • EPS Growth
  • CDT N/A
  • HCTI N/A
  • EPS
  • CDT N/A
  • HCTI N/A
  • Revenue
  • CDT N/A
  • HCTI $11,291,000.00
  • Revenue This Year
  • CDT N/A
  • HCTI N/A
  • Revenue Next Year
  • CDT N/A
  • HCTI N/A
  • P/E Ratio
  • CDT N/A
  • HCTI N/A
  • Revenue Growth
  • CDT N/A
  • HCTI N/A
  • 52 Week Low
  • CDT $2.21
  • HCTI $0.01
  • 52 Week High
  • CDT $1,844.85
  • HCTI $1.90
  • Technical
  • Relative Strength Index (RSI)
  • CDT 31.11
  • HCTI 39.68
  • Support Level
  • CDT $2.21
  • HCTI $0.02
  • Resistance Level
  • CDT $2.58
  • HCTI $0.04
  • Average True Range (ATR)
  • CDT 0.19
  • HCTI 0.01
  • MACD
  • CDT 0.23
  • HCTI 0.01
  • Stochastic Oscillator
  • CDT 54.45
  • HCTI 44.72

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.

Share on Social Networks: